share_log

Citigroup Initiates Coverage On Alpha Tau Medical With Buy Rating, Announces Price Target of $8

Citigroup Initiates Coverage On Alpha Tau Medical With Buy Rating, Announces Price Target of $8

花旗集團以買入評級啓動對Alpha Tau Medical的保險,宣佈目標股價爲8美元
Benzinga ·  2023/12/15 09:43

Citigroup analyst Ashiq Mubarack initiates coverage on Alpha Tau Medical (NASDAQ:DRTS) with a Buy rating and announces Price Target of $8.

花旗集團分析師阿希克·穆巴拉克以買入評級開始對Alpha Tau Medical(納斯達克股票代碼:DRTS)進行報道,並宣佈目標股價爲8美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論